Zevra Therapeutics (ZVRA) Invested Capital (2014 - 2026)
Zevra Therapeutics' Invested Capital was $217.65 million in Q2 2026, up 22.3% from $177.92 million a year earlier and up 5.8% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Invested Capital (2014 - 2026) Analysis & Trends
For FY2025, Invested Capital at Zevra Therapeutics came in at $216.59 million, up 118.4% from FY2024.
- In earlier years, Invested Capital was $99.17 million in FY2024 (-5.2%), $104.63 million in FY2023 (+19.0%), $87.92 million in FY2022 (-13.5%) and $101.66 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Invested Capital in data going back to Q4 2014.
- Compared with a year earlier, Invested Capital has increased for six straight quarters, with growth averaging 53.9% over the last eight quarters.
- The best year-over-year quarter for Invested Capital over five years was Q4 2025 (growth of 118.4%); the worst was Q1 2023 (a decline of 40.6%).
- Per Business Quant data, ZVRA's Invested Capital in the three quarters before Q2 2026 was $205.8 million (Q1 2026), $216.59 million (Q4 2025) and $194.48 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Zevra Therapeutics | 592.83 Mn | -219.88 Mn | 38.18 Mn | 217.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 217.65 Mn |
| Mar 31, 2026 | 205.80 Mn |
| Dec 31, 2025 | 216.59 Mn |
| Sep 30, 2025 | 194.48 Mn |
| Jun 30, 2025 | 177.92 Mn |
| Mar 31, 2025 | 101.11 Mn |
| Dec 31, 2024 | 99.17 Mn |
| Sep 30, 2024 | 128.67 Mn |
| Jun 30, 2024 | 90.81 Mn |
| Mar 31, 2024 | 86.76 Mn |
| Dec 31, 2023 | 104.63 Mn |
| Sep 30, 2023 | 100.32 Mn |
| Jun 30, 2023 | 71.58 Mn |
| Mar 31, 2023 | 72.18 Mn |
| Dec 31, 2022 | 87.92 Mn |
| Sep 30, 2022 | 106.59 Mn |
| Jun 30, 2022 | 112.03 Mn |
| Mar 31, 2022 | 121.50 Mn |
| Dec 31, 2021 | 101.66 Mn |
| Sep 30, 2021 | 131.74 Mn |
API Access
Zevra Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();